Published in Lab Business Week, January 23rd, 2005
In addition, the company has granted the initial purchasers of the notes an option to purchase up to an additional $75 million principal amount of notes. The notes will be convertible into common stock of the company at a conversion rate of 78.0153 shares per $1,000 principal amount of notes (representing an initial conversion price of approximately $12.82 per share) and will accrue interest at an annual rate of 1.75%.
The notes will mature in December...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.